Diabetes-Induced Changes in Macrophage Biology Might Lead to Reduced Risk for Abdominal Aortic Aneurysm Development

Area of Science:

• Vascular Biology
• Metabolic Disease
• Immunology

Background:

• Macrophages are key players in abdominal aortic aneurysm (AAA) pathogenesis.
• Type 2 diabetes mellitus (T2DM) is paradoxically associated with a reduced incidence of AAA.
• Diabetes-induced alterations in macrophage biology may underlie this protective effect.

Purpose of the Study:

• To investigate the impact of diabetes on macrophage metabolism and function.
• To determine if serum from diabetic patients alters macrophage metabolic profiles.
• To explore the link between altered macrophage metabolism and reduced AAA risk in diabetes.

Main Methods:

• Primary human macrophages were cultured.
• Macrophages were treated with serum from non-diabetic versus diabetic patients with AAA.
• Extracellular acidification, gene expression (glycolysis, lipid oxidation), and metabolic profiles were analyzed.

Main Results:

• Serum from diabetic AAA patients increased macrophage metabolism, indicated by extracellular acidification.
• Gene expression analysis suggested enhanced glycolysis and lipid oxidation in macrophages treated with diabetic serum.
• These metabolic changes were not attributable to differences in serum glucose levels.
• Increased macrophage metabolism correlated with a shift towards an anti-inflammatory phenotype.

Conclusions:

• Diabetes induces metabolic changes in macrophages.
• These diabetes-induced metabolic alterations promote an anti-inflammatory macrophage state.
• This metabolic reprogramming may explain the reduced risk of abdominal aortic aneurysm development in type 2 diabetes patients.